Cited by 298Antifungal resistance and susceptibilityFungal Plant Pathogen ControlFungal Infections and Studies

The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.

Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

Open access

Cuenca-Estrella, Manuel, Gomez-Lopez, Alicia, Mellado, Emilia, Buitrago, Maria J., Monzon, Araceli, Rodriguez-Tudela, Juan Luis·2006·Antimicrobial Agents and Chemotherapy

DOI 10.1128/aac.50.3.917-921.2006PMC PMC1426453

Open this paper in CoChat — free account

Abstract

We have compared the activities of posaconazole and other currently available antifungal agents against a collection of 3,378 clinical isolates of yeasts and filamentous fungi. A total of 1,997 clinical isolates of Candida spp., 359 of other yeast species, 697 strains of Aspergillus spp., and 325 nondermatophyte non- Aspergillus spp. were included. The average geometric means of the MICs of agents that were tested against Candida spp. were 0.23 μg/ml for amphotericin B, 0.29 μg/ml for flucytosine, 0.97 μg/ml for fluconazole, 0.07 μg/ml for itraconazole, 0.04 μg/ml for voriconazole, 0.15 μg/ml for caspofungin, and 0.03 μg/ml for posaconazole. Voriconazole and posaconazole were active in vitro against the majority of isolates, with resistance to fluconazole and itraconazole, and against Cryptococcus neoformans and other Basidiomycota yeasts. Posaconazole was the most active of antifungal agents tested against Aspergillus spp., with an average geometric mean of 0.10 μg/ml. It was active against Paecilomyces spp., Penicillium spp., Scedosporium apiospermum , and some black fungi, such as Alternaria spp. Multiresistant filamentous fungi, such as Scedosporium prolificans , Scopulariopsis brevicaulis , and Fusarium solani , were also resistant to voriconazole, caspofungin, and posaconazole. Amphotericin B and posaconazole were found to be active against most of the Mucorales strains tested. Posaconazole and currently available antifungal agents exhibit a potent activity in vitro against the majority of pathogenic fungal species.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1128/aac.50.3.917-921.2006

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · PEDIATRICS · doi:10.1542/peds.65.1.187 · Cited by 14,736
Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000
Pfaller, M. A., Messer, S. A., Hollis, R. J., & Jones, R. N. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.1032-1037.2002 · Cited by 405
Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi
Diekema, D. J., Messer, S. A., Hollis, R. J., Jones, R. N., & Pfaller, M. A. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.8.3623-3626.2003 · Cited by 370
Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults
Courtney, R., Wexler, D. B., Radwanski, E., Lim, J. M., & Laughlin, M. A. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01977.x · Cited by 328
In vitro susceptibilities of zygomycetes to conventional and new antifungals
Dannaoui, É. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg020 · Cited by 312
Experimental Pulmonary Aspergillosis Due toAspergillus terreus:Pathogenesis and Treatment of an Emerging Fungal Pathogen Resistant to Amphotericin B
Walsh, T. J., Petraitis, V., Petraitienė, R., Field‐Ridley, A., Sutton, D. A., Ghannoum, M. A., Sein, T., Schaufele, R. L., Peter, J., Bacher, J. D., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377210 · Cited by 252
Untitled work
(2003) · PubMed · Cited by 240
Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection
Denning, D. W. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/40.3.401 · Cited by 234
In Vitro Activities of New and Conventional Antifungal Agents against ClinicalScedosporiumIsolates
Meletiadis, J., Meis, J. F. G. M., Mouton, J. W., Rodriquez-Tudela, J. L., Donnelly, J. P., Verweij, P. E., & the EUROFUNG Network (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.62-68.2002 · Cited by 232
Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum
Cuenca‐Estrella, M., Ruiz-Dı́ez, B., Martı́nez-Suárez, J. V., Monzón, A., & Rodrı́guez-Tudela, J. L. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.1.149 · Cited by 211
Self-citation

Show all 32 references

Research works printed but not linked: 1

Keating, G. M. 2006. Posaconazole. Drugs65:1553-1567.

Sorted by citations

Items 201–298 of 298

Two cases of fungemia due to Lomentospora prolificans in haematological patients with different outcome
Cobo, F., González-Sierra, P. A., Ortega-Gavilán, M. C., Castellano-Sánchez, L., & Navarro‐Marí, J. M. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116527 · Cited by 11
Management of Chemotherapy-Induced Neutropenic Fever
Bhardwaj, A. S., & Navada, S. C. (2013) · Hospital Practice · doi:10.3810/hp.2013.02.1015 · Cited by 11
Development, clinical utility, and place in therapy of posaconazole for prevention and treatment of invasive fungal infections
Klepser, M. E. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s7773 · Cited by 11
Posaconazole prophylaxis during induction therapy of patients with acute lymphoblastic leukaemia
Illmer, T., Babatz, J., Pursche, S., Stölzel, F., Schuler, U. S., Schaich, M. A., & Ehninger, G. (2010) · Mycoses · doi:10.1111/j.1439-0507.2010.01860.x · Cited by 11
Actividad antifúngica in vitro de voriconazol: Nuevos datos después de los primeros años de experiencia clínica
Quindós, G., Carrillo‐Muñoz, A. J., Eraso, E., Cantón, E., & Pemán, J. (2007) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(07)70043-8 · Cited by 11
New antifungal agents for the treatment of candidaemia
Muñóz, P., Guinea, J., Rojas, L., & Bouza, E. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.11.007 · Cited by 10
Species Distribution andin VitroSusceptibility ofCandidaBloodstream Isolates to Six New and Current Antifungal Agents in a Turkish Tertiary Care Military Hospital, Recovered Through 2001 and 2006
Saraçlı, M. A., Gümral, R., Gül, H. C., Gönlüm, A., & Yıldıran, Ş. T. (2009) · Military Medicine · doi:10.7205/milmed-d-04-7808 · Cited by 9
Fusarioses diagnostiquées au laboratoire d’un CHU en Tunisie : étude épidémiologique, clinique et mycologique
Néji, S., Trabelsi, H., Cheikhrouhou, F., Sellami, H., Guidara, R., Trigui, A., Feki, J., Boudaya, S., Turki, H., Makni, F., et al. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.04.003 · Cited by 10
Étude in vitro de la sensibilité au posaconazole de souches de Scytalidium spp. isolées de lésions superficielles
Dunand, J., & Paugam, A. (2008) · Pathologie Biologie · doi:10.1016/j.patbio.2007.12.006 · Cited by 10
Antifungal drug resistance in molds: Clinical and microbiological factors
Alcázar‐Fuoli, L., Rodrı́guez-Tudela, J. L., & Mellado, E. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0006-2 · Cited by 10
Self-citation
Actividad antifúngica in vitro de la micafungina
Quindós, G., Eraso, E., Carrillo‐Muñoz, A. J., Cantón, E., & Pemán, J. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70006-3 · Cited by 9
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia
Kubisiak-Rzepczyk, H., Gil, L., Zawirska, A., Kubisiak-Michalska, A., Mól, A., Reich, A., Komarnicki, M., & Adamski, Z. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.08.003 · Cited by 10
Uncommon Fungi and Related Species
Hospenthal, D. R. (2015) · Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases · doi:10.1016/b978-1-4557-4801-3.00270-8 · Cited by 10
Dipodascus capitatus (Geotrichum capitatum): infecção sistêmica fatal em paciente com leucemia mielocítica aguda
Lafayette, T. C. S., de Oliveira, L. T. O., Landell, M. F., Valente, P., Alves, S. H., & Pereira, W. V. (2011) · Revista da Sociedade Brasileira de Medicina Tropical · doi:10.1590/s0037-86822011000500028 · Cited by 10
Actualités sur le posaconazole
Paugam, A. (2007) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2006.11.002 · Cited by 10
Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients
Escamilla, J. E., January, S. E., & Guillamet, R. V. (2023) · Pathogens · doi:10.3390/pathogens12050694 · Cited by 9
Efficacy of oleylphosphocholine (Ol PC ) in vitro and in a mouse model of invasive aspergillosis
Paulussen, C., Boulet, G., Bosschaerts, T., Cos, P., Fortin, A., & Maes, L. J. R. M. (2015) · Mycoses · doi:10.1111/myc.12286 · Cited by 9
Blood and tissue distribution of posaconazole in a rat model of invasive pulmonary aspergillosis
Cendejas‐Bueno, E., Forastiero, A., Ruíz-Camps, I., Mellado, E., Gavaldà, J., & Gómez‐López, A. (2016) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2016.10.010 · Cited by 9
Self-citation
Breakthrough disseminated Saprochaete capitata infection in a child with acute myeloid leukaemia receiving caspofungin therapy
Purohit, P., Al-Obaid, I., Al‐Oneizi, E., Al‐Hindi, O., Joseph, L., Ahmad, S., & Khan, Z. (2014) · JMM Case Reports · doi:10.1099/jmmcr.0.001750 · Cited by 9
Emerging fungal pathogens in pulmonary disease
Sanchez, A., & Larsen, R. A. (2007) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3280f6cedc · Cited by 9
Epidemiology of Invasive Candidiasis and Challenges for the Mycology Laboratory: Specificities of Candida glabrata
Sampaio, P., & Pais, C. (2014) · Current Clinical Microbiology Reports · doi:10.1007/s40588-014-0002-y · Cited by 8
Disseminated fungal infection by Aureobasidium pullulans in a renal transplant recipient
Nalçacıoğlu, H., Yakupoğlu, Y. K., Genç, G., Belet, N., Şensoy, S. G., Bırıncı, A., & Özkaya, O. (2018) · Pediatric Transplantation · doi:10.1111/petr.13152 · Cited by 8
Pruebas moleculares en el diagnóstico micológico
Rodrı́guez-Tudela, J. L., Cuesta, I., Gómez‐López, A., Alastruey‐Izquierdo, A., Bernal‐Martínez, L., & Cuenca‐Estrella, M. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13128780 · Cited by 8
Self-citation
Actividad antifúngica in vitro de la anidulafungina
Quindós, G., & Eraso, E. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70025-1 · Cited by 8
Antifungal Activities of Camellia Sinensis Crude Extract on Selected Pathogenic and Mycotoxic Fungi
Sigei, E. C. (2014) · Cited by 8
Actividad antimicótica del aceite esencial a partir de Eucalyptus tereticornis sobre el hongo patógeno Fusarium oxysporum
Arango, W. M., Ruiz, J. M. A., & Jaramillo, C. A. P. (2011) · Institutional Repository University of Antioquia (University of Antioquia) · Cited by 7
Candidemia: impacto de los estudios epidemiológicos en la terapéutica y en el pronóstico de una infección grave
Almirante, B., & Cuenca‐Estrella, M. (2011) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2011.03.002 · Cited by 5
Self-citation
Disseminated Intravascular Infection Caused by Paecilomyces variotii: Case Report and Review of the Literature
Lazarus, J. E., Branda, J. A., Gandhi, R. G., Barshak, M. B., Zachary, K. C., & Barczak, A. K. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa166 · Cited by 6
Fungemia due to Aureobasidium pullulans
Verdecia, J., Jankowski, C. A., Reynolds, M. L., McCarter, Y. S., & Ravi, M. (2022) · Medical Mycology Case Reports · doi:10.1016/j.mmcr.2022.06.004 · Cited by 6
Diagnostic Direct DNA Sequencing and Systemic Treatment with Voriconazole in Scedosporium apiospermum Keratitis? A Case Report
Zhang, X. X. Q.-Q. (2013) · Journal of Clinical & Experimental Ophthalmology · doi:10.4172/2155-9570.1000299 · Cited by 6
Espectro y factores de riesgo de la infección fúngica invasora
Castón, J. J., Román, A. R., & Torre‐Cisneros, J. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13108710 · Cited by 6
Infection fongique disséminée à Magnusiomyces capitatus chez un patient transplanté hépatique
Yapo-Kouadio, C. G., Hasseine, L., Goubaux, B., & Gari-Toussaint, M. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.05.002 · Cited by 5
Antifungal Therapy in Eye Infections: New Drugs, New Trends
Joseph, J., & Sharma, S. (2016) · Springer eBooks · doi:10.1007/978-81-322-2782-3_9 · Cited by 6
Pulmonary Scedosporium apiospermum Infection with Pulmonary Tumorlet in an Immunocompetent Patient
Motokawa, N., Miyazaki, T., Hara, A., Fukuda, Y., Morino, S., Nakamura, H., Iwasaki, K., Soda, H., Izumikawa, K., Yanagihara, K., et al. (2018) · Internal Medicine · doi:10.2169/internalmedicine.1239-18 · Cited by 5
Cutaneous Infections by Geotrichum spp.
Román-Montes, C. M., Sifuentes‐Osornio, J., & Martínez‐Gamboa, A. (2024) · Current Fungal Infection Reports · doi:10.1007/s12281-024-00481-9 · Cited by 5
Post-operative endophthalmitis due to Fusarium dimerum.
Khan, S. H., Pillai, G. S., Vivek, V. J., Dinesh, K. R., & Karim, P. (2012) · PubMed · Cited by 5
A fatal invasive Scedosporium apiospermum pulmonary infection in an adult patient with malignant lung adenocarcinoma
Sav, H., Altınbaş, R., & Dursun, Z. B. (2020) · Current Medical Mycology · doi:10.18502/cmm.6.3.3982 · Cited by 5
Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
Mohaghegh, F., Abtahi‐Naeini, B., Nasri, E., Badiee, P., Morovati, H., Fakhim, H., Farmani, A., Meidani, M., Ranjbar‐Mobarake, M., & Mohammadi, R. (2022) · Journal of Medical Case Reports · doi:10.1186/s13256-022-03575-5 · Cited by 5
Paecilomyces/Purpureocillium Infection in Children, Case Report, and Review of the Literature
Alharbi, M., Alruqaie, N., Alzahrani, A., & Almuneef, M. A. (2022) · Journal of Fungi · doi:10.3390/jof8090930 · Cited by 4
Systemic Antifungals
Oak, A. S. W., Baddley, J. W., & Elewski, B. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-66884-0_40 · Cited by 4
Saprochaete/Magnusiomyces: identification, virulence factors, and antifungal susceptibility of a challenging rare yeast
Kaşaltı, B., & Gülmez, D. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-024-01248-7 · Cited by 3
Systemic Scedosporium apiospermum Infection Affecting Multiple Sites After Near-Drowning: A Case Report
Zhang, A., Wang, Z., Sheng, H., & Yang, J. (2024) · Infection and Drug Resistance · doi:10.2147/idr.s483524 · Cited by 3
Emergence and Evolution of Antifungal Resistance
Edlind, T. D. (2014) · ASM Press eBooks · doi:10.1128/9781555815639.ch25 · Cited by 3
Antifungal Mechanisms of Action and Resistance
Perlin, D. S., & Mellado, E. (2014) · ASM Press eBooks · doi:10.1128/9781555815523.ch34 · Cited by 3
Self-citation
Fusarium solani species complex infection treated with posaconazole in a liver transplantation patient; a case report
Avkan-Oğuz, V., Karabıçak, N., Irmak, Ç., & Ünek, T. (2023) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2023.101382 · Cited by 3
Situación actual de las infecciones fúngicas invasivas. Las nuevas técnicas diagnósticas y los nuevos antifúngicos
Gurguí, M., & Cuenca‐Estrella, M. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76586-8 · Cited by 3
Self-citation
Fusarium incarnatum/equiseti Hemodialysis Graft Infection
Riddell, J., Woodside, K. J., Leavitt, M. A., Newton, D. W., & Punch, J. D. (2010) · Infectious Disease Reports · doi:10.4081/idr.2010.1939 · Cited by 3
Fungal infections in solid organ transplantation
Sanchez, A., & Larsen, R. A. (2007) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3282f1fc12 · Cited by 3
In vitro susceptibility of non-Aspergillus allergenic fungal species to azoles
Duddy, N. E., Moore, C. B., Howard, S. J., & Denning, D. W. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp023 · Cited by 3
Emerging Fungal Cutaneous Infections in Immunocompromised Patients
Chandorkar, A., & Simkins, J. (2020) · Current Fungal Infection Reports · doi:10.1007/s12281-020-00395-2 · Cited by 3
Novel Antifungal Therapies
Abu‐Elteen, K. H., & Hamad, M. M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6397-8_4 · Cited by 3
The Brief Case: Cutaneous ulceration associated with acalabrutinib treatment
Luzarraga, V., Nourrisson, C., Anglade, F., Chevenet, C., Poirier, P., & Moniot, M. (2025) · Journal of Clinical Microbiology · doi:10.1128/jcm.01583-24 · Cited by 2
Use of phylogenetical analysis to predict susceptibility of pathogenic Candida spp. to antifungal drugs
Maheux, A. F., Sellam, A., Piché, Y., Boissinot, M., Pelletier, R., Boudreau, D. K., Picard, F. J., Trépanier, H., Boily, M.-J., Ouellette, M., et al. (2016) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2016.09.020 · Cited by 2
Tratamiento actual de la candidemia. Papel de anidulafungina
Almirante, B., & Pemán, J. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76589-3 · Cited by 2
The role of second-generation triazole antifungal agents voriconazole and posaconazole in patients with hematologic malignancies
Bow, E. J., & Bacteriol, D. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0005-y · Cited by 2
Human Fungal Pathogens and Drug Resistance Against Azole Drugs
Bhetariya, P. J., Sharma, N., Singh, P., Tripathi, P., Upadhyay, S. K., & Gautam, P. (2017) · Springer eBooks · doi:10.1007/978-3-319-48683-3_18 · Cited by 3
Drug susceptibility of Candida isolated from the surfaces of mobile phones and hands
Kordecka, A., Krajewska-Kułak, E., Łukaszuk, C. R., Kraszyński, M., & Kraszyńska, B. (2017) · Progress in Health Sciences · doi:10.5604/01.3001.0010.1861 · Cited by 2
Non-Aspergillus Fungal Infections in Transplant Patients
Revankar, S. G. (2021) · Springer eBooks · doi:10.1007/978-3-030-25869-6_46 · Cited by 2
Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. – case report and brief literature review
Bosetti, D., Spoerl, D., Riat, A., Vito, C. D., Masouridi‐Levrat, S., Chalandon, Y., & Neofytos, D. (2022) · Swiss Medical Weekly · doi:10.57187/smw.2022.40011 · Cited by 2
El diagnóstico molecular en las infecciones parasitarias y fúngicas
Salvador, R. B., Cuenca‐Estrella, M., Márquez, M. V. D., & Gironés, I. G. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76541-8 · Cited by 2
Self-citation
Posaconazole Oral Suspension
Cada, D. J., Levien, T. L., & Baker, D. E. (2007) · Hospital Pharmacy · doi:10.1310/hpj4201-57 · Cited by 2
Necrotizing orbital infections: A comprehensive review
Pakdel, F., Salehi, M., Darazam, I. A., Salahshour, F., Khalili, H., Shafaati, M., Marashi, M., Sarvestani, H. K., Mahmoudi, P. S., Ashraf, D. C., et al. (2025) · Saudi Journal of Ophthalmology · doi:10.4103/sjopt.sjopt_87_25 · Cited by 1
Levoglucosenone‐Derived Isothiocyanates as Antifungal Compounds: Merging Sustainability and Medicinal Chemistry
Cámpora, F., Pava-Gómez, B. E., Vázquez, D., Sortino, M. A., Svetaz, L. A., Mangione, M. I., Suárez, A. G., Sarotti, A. M., Matassini, C., Cardona, F., et al. (2026) · ChemMedChem · doi:10.1002/cmdc.70357 · Cited by 1
Expansion of a recent class of broad-spectrum antifungal agents: the echinocandins
Manfredi, R. (2009) · Microbiologia medica · doi:10.4081/mm.2009.2522 · Cited by 1
[Interstitial cancerous lung diseases. Lymphangiosis carcinomatosa and leukemic pulmonary infiltrates].
Dinkel, E., Meyer, E. C., Mundinger, A., Helwig, A., Blum, U., & Würtemberger, G. (1990) · PubMed · Cited by 1
Real-Life Challenges to the Use of Antifungal Agents in Hematology Patients
Perissinotti, A. J., & Marini, B. L. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0303-8 · Cited by 1
Posaconazole : un nouvel antifongique pour quelles indications ?
Bretagne, S. (2008) · Antibiotiques · doi:10.1016/j.antib.2007.12.001 · Cited by 1
Análise da prevalência e perfil de suscetibilidade das espécies de Candida isoladas de hemoculturas em 2006 no Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Motta, A. L. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2009.tde-24092009-151713 · Cited by 1
Caracterização molecular, virulência e suscentibilidade ao fluconazol de espécies ambientais de 'Cryptococcus', antes e após inoculação em modelo murino
Pedroso, R. D. S. (2008) · doi:10.11606/t.60.2008.tde-18082008-133009
Peritonitis fúngicas
Miguel, A. M., & Erro, M. C. R. (2009) · Elsevier eBooks · doi:10.1016/b978-84-8086-394-0.50017-4
Avaliação da formação de biofilme de fungos emergentes e sua susceptibilidade a antifúngicos na forma livre e nanoencapsulada
de Jesus, R. S. (2013) · Americanae (AECID Library)
Estudio de sensibilidad antifúngica para posaconazol y caspofungina en levaduras responsables de infección fúngica invasiva (2002-2003). Evaluación del sistema E-test
Fernández, A., Velasco, D., Lueiro, F., & Bou, G. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13115542
Correlación entre las CIM de itraconazol, voriconazol y posaconazol en Aspergillus fumigatus
Guinea, J., Peláez, T., Alcalá, L., & Bouza, E. (2007) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13102276
Clinical Microbiology Reviews(CMR)
Coburn, B. A., Sekirov, I., Finlay, B. B., Finlay, Dykes, C., & Demeter, L. M. (2007)
antimycotic agents: the role of echinocandins today
Manfredi, R. (2010)
Lo que debemos saber sobre los métodos de sensibilidad a los antifúngicos What we must know about antifungal suceptibility testing
Zapata, F., & Cardona-Castro, N. M. (2012)
Relato de Caso Case Report
Christina, T., Lafayette, S., Therezinha, L., Oliveira, O., Landell, M. F., Valente, P., Alves, S. H., & Pereira, W. V. (2011)
Infections dues à Trichosporon spp. et à Geotrichum spp.
Bonhomme, J. (2015)
Efeito inibitório in vitro de ciprofloxacina isolada e em combinação com antifúngicos frente a Coccidioides posadasii e Histoplasma capsulatum var. capsulatum
Caetano, É. P. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Tsunami Lung in Great East Japan Earthquake 2011: Clinical Time Course, Feature, Pathogenesis, and Treatment
Yamauchi, K., Nagashima, H., Nakadate, T., & Nakamura, Y. (2018) · Respiratory disease series · doi:10.1007/978-981-13-2598-4_2
Antifungal Consideration for Transplant Recipients
Dubrovskaya, Y., Merl, M. Y., Perlin, D. S., & Safdar, A. (2019) · Springer eBooks · doi:10.1007/978-1-4939-9034-4_52
Non-Aspergillus Fungal Infections in Transplant Patients
Revankar, S. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-01751-4_46-1
Antifungal Agents
Lockhart, S. R., & Warnock, D. W. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch129
Candida-Blutkulturisolate in Deutschland und Österreich
Kumm, K. (2008) · doi:10.53846/goediss-717
Antifungal Agents
Warnock, D. W. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch126
Human Hyalohyphomycoses
Perfect, J. R. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-21
Fusarium solani
Masson, R. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1241-0_30
Fusarium solani
Masson, R. (2024) · Springer eBooks · doi:10.1007/978-3-031-60954-1_42
Antifungal Agents
Lockhart, S. R., & Berkow, E. L. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0133
Non-Aspergillus Pulmonary Mold Infections
Muthu, V., & Chakrabarti, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-76524-7_25
Antifungal Agents
Lockhart, S. R., & Berkow, E. L. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0133
A Rare Case of Alternaria citri Keratitis Successfully Treated with Voriconazole
Bertazzolo, M., Boaretto, G., Zani, E. M., Busin, M., Cruciani, D., Crotti, S., Poletti, C., Vatri, R., Caracciolo, A., & Lapucci, C. (2025) · Journal of Fungi · doi:10.3390/jof11110805
Usual Susceptibility Patterns of Common Moulds and Systemic Fungi
Hall, G. S. (2011) · Humana Press eBooks · doi:10.1007/978-1-59745-134-5_6
Comparing Efficacy and Safety of Itraconazole Solution Versus Posaconazole for Antifungal Prophylaxis After Heart Transplant
Tayyar, R., Drucker, D., Lee, R., Lê, T. H., Teuteberg, J. J., Khush, K. K., Luikart, H. I., Intrieri, T. A., Moayedi, Y., Alegria, W., et al. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag104
Evaluation de l'activité antimicrobienne de nouveaux composés aminostéroïdiens dans le contexte de la mucoviscidose
Alhanout, K. (2010) · doi:10.70675/b25730f4zedecz4b6az967azd8dcbd755711
Emerging Antifungal Resistance in Ocular Infections
de Oliveira, H. C., Tabuse, A. M., Höfling-Lima, A. L., & Rodrigues, A. M. (2026) · Springer eBooks · doi:10.1007/978-3-032-19923-2_3
Ocular Drug Delivery of Antifungal Agents
Dasgupta, O., Mannangatty, T., Sankar, S., Khandagale, N., Kailasam, V., Malani, M., Garg, P., & Nirmal, J. (2026) · Springer eBooks · doi:10.1007/978-3-032-19923-2_2
Advances in Azole Antifungal Agents: From Structural Foundations to Resistance Challenges
Yin, Y., Lu, W., Zhao, M., & Zhao, Y. (2026) · Journal of Fungi · doi:10.3390/jof12100728

Authors: Cuenca-Estrella, M., Gomez-Lopez, A., Mellado, E., Buitrago, M. J., Monzon, A., & Rodriguez-Tudela, J. L.
Affiliations: Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain
Instituto de Salud Carlos III (ES)
ORCID: Mellado, Emilia
Venue: Antimicrobial Agents and Chemotherapy
Publisher: American Society for Microbiology
Published: 2006-03
Volume: 50
Issue: 3
Pages: 917-921
ISSN: 0066-4804 (ISSN-L)
1098-6596
DOI: 10.1128/aac.50.3.917-921.2006
PMC: PMC1426453
OpenAlex: W2160917189
Cited by: 298
References: 32
Citations by year: 2026: 5 · 2025: 4 · 2024: 6 · 2023: 6 · 2022: 5 · 2021: 9 · 2020: 11 · 2019: 3 · 2018: 8 · 2017: 10 · 2016: 12 · 2015: 10 · 2014: 20 · 2013: 14 · 2012: 9
FWCI: 23.42
Type: journal article
Language: en
Open access: green
europepmc.org
Licence: journals.asm.org/non-commercial-tdm-license (tdm)
Locations: Antimicrobial Agents and Chemotherapy (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
Keywords: posaconazole, antifungal agents, clinical fungal isolates, Candida, Aspergillus, filamentous fungi, antifungal susceptibility, minimum inhibitory concentration, voriconazole resistance, caspofungin, amphotericin B, fluconazole resistance, itraconazole, Cryptococcus neoformans, Scedosporium prolificans, Scedosporium apiospermum, Paecilomyces, Penicillium, Mucorales, black fungus, Spanish isolates
MeSH terms: Caspofungin, Amphotericin B, Antifungal Agents, Flucytosine, Fungi, Humans, Microbial Sensitivity Tests, Mycoses, Peptides, Cyclic, Pyrimidines, Spain, Triazoles, Yeasts, Fluconazole, Itraconazole, Echinocandins, Lipopeptides, Voriconazole

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks